Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

Researchers describe the symptom profiles of respiratory viral infections.

Jazz Pharma’s Enrylaze wins European approval for AML and LBL – Pharmaceutical Technology

A 3D illustration showing abundant lymphoblasts in blood. Enrylaze, sold as RylaZe in the US and Canada, was approved by the US Food and Drug

September 22, 2023

Curaleaf Q2 Revenue Lifts 1% Sequentially

Curaleaf Reports Second Quarter 2023 Results Second quarter 2023 revenue of $339 million, representing an increase of 4% year-over-year, and adjusted EBITDA¹ of $70 million

August 10, 2023

Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer – Biotech Investments

New York, 10/29/2024 / 11:10, EST/EDT – EQS Newswire – Laxxon Medical Laxxon Medical Corp., a leading pharma technology platform company focusing on oral drug

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.